Vascular Flow has appointed Vascutek as an exclusive regional distributor in France, Germany, Austria and Switzerland.
Vascutek has a significant presence Europe, a wide-reaching distribution network and a portfolio of vascular products that includes a range of sealed, woven and knitted polyester grafts for peripheral, abdominal and cardiothoracic surgery. The distribution agreement will introduce Vascular Flow’s Spiral Flow peripheral bypass and arterio venous grafts to the vascular and cardiovascular clinicians that are serviced by this network.
Data presented at the recent VEITH symposium (November 2014) showed a 30% increase in one-year success rates for vascular bypass surgery and dramatic reduction in amputations in patients receiving a Spiral Flow peripheral bypass graft compared to those who received a standard PTFE graft. Earlier this year the company also announced the start of a 24-month, randomised, controlled clinical study of its arterio venous graft in haemodialysis access, using current best practice as a comparator. The data from this study will be used to support health economic evaluation.
Bill Allan, chief executive officer of Vascular Flow, said: “France, Germany, Austria and Switzerland have significant potential for adoption of the Spiral Flow technology grafts and we are confident this growth will accelerate further with the sustained presence provided by the strength of the Vascutek organisation and distribution network.”
